Press monitoring
Halozyme Initiates First Enhanze Technology Clinical Trial to Improve the Subcutaneous Absorption of a Large Molecule Protein Therapeutic
18.8.2006 | Press monitoring
Halozyme Therapeutics, Inc. (Amex: HTI), a biopharmaceutical company developing and commercializing recombinant human enzymes, today announced it has initiated and dosed the first three patients in a clinical trial of Enhanze® Technology, Halozyme's enzyme-based drug delivery platform based on recombinant human PH20 hyaluronidase (rHuPH20),...
Nanotechnology being used to improve biocompatibility of human prosthetics and implants
18.8.2006 | Press monitoring
Nanostructures and osteoblast behavior of thermal sprayed calcium phosphate splats
Superconducting MR Spectrometer
17.8.2006 | Press monitoring
A state-of-the-art superconducting magnet has recently been developed for use in researching biologic macromolecules such as DNA, RNA, enzymes, and other proteins.
New Gene Allows Rice to Survive Submersion
17.8.2006 | Press monitoring
Rice, like most plants, needs water. In fact, it needs more water than most: the shoots of this marsh plant are typically partially submerged. But rice, like most crops, still does not stand up to total submersion. Despite being the staple of flood-prone regions, most strains of rice die if submerged for more than four days and even short-term...
Human Genome seeks approval for lupus drug trial
17.8.2006 | Press monitoring
BOSTON (Reuters) - Biotechnology company Human Genome Science Inc. said on Wednesday that it plans shortly to seek approval from U.S. regulators to run a late-stage clinical trial of its drug to treat systemic lupus erythematosus, a chronic, life-threatening disease.
GM techniques turn a plant parasite into a potential saviour of rice producers
17.8.2006 | Press monitoring
Crown gall disease is a proud gardener's worst nightmare. I visit Lindsay Stockley and she looks despondent when she greets me. She has just diagnosed the disease in a number of trees in the orchard that she tends and things are looking grim.
Anti-obesity vaccine
17.8.2006 | Press monitoring
US scientists have devloped an anti-obesity vaccine that significantly slowed weight gain and cut body fat in animals.
Test tube pregnancy less likely with frozen eggs
17.8.2006 | Press monitoring
NEW YORK (Reuters Health) - In vitro fertilization (IVF), a popular type of test tube fertility technique, is less likely be successful in the mother's eggs have been frozen and stored, researchers report in the journal Fertility and Sterility.
Scientists take step toward obesity vaccine
17.8.2006 | Press monitoring
NEW YORK (Reuters Health) - In what could become a new weapon in the battle of the bulge, scientists on Monday reported initial success with an experimental vaccine for obesity.
A more powerful and efficient engine for rice: the C3-C4 challenge
17.8.2006 | Press monitoring
Los Baños, Philippines – A major international scientific effort was launched last week to develop and use a radical new approach to boost rice production and avoid potential rice shortages, or even future famine.
